H

Heart House Research Foundation | Springfield, OH

Research site
(Unclaimed)
Location
100 West McCreight Avenue, Suite 150, Springfield, Ohio, United States of America
Site insights

Top conditions

Heart Failure (3 trials)

Supraventricular Tachycardia (2 trials)

Coronary Artery Disease (2 trials)

Infarction (2 trials)

Myocardial Infarction (2 trials)

Top treatments

Etripamil
Aspirin
Evolocumab
Iron
losartan
sodium
lisinopril

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 10
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

Trial sponsors

Amgen logo

Amgen (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems